Xcout Intel
Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company that develops novel immunotherapies and macrophage-targeting treatments for cancer patients. Its lead candidate, bexmarilimab, is an anti-Clever-1 antibody being evaluated in clinical trials for hematological cancers and solid tumors to improve the efficacy of standard cancer treatments.
Subscribe to see Faron Pharmaceuticals Oy’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Faron Pharmaceuticals Oy at a glance
Faron Pharmaceuticals Oy is a health care company headquartered in Finland. Xcout tracks 6 named people at Faron Pharmaceuticals Oy, including Tuomo Pätsi (Non-Executive Chairman).
Faron Pharmaceuticals Oy leadership
- Tuomo PätsiNon-Executive Chairman
- Juho JalkanenCEO and Founder
- Christine RothNon-executive Director
- Colin BondNon-executive Director
- George Stanley GolumbeskiNon-executive Director
- Marie-Louise FjällskogNon-executive Director
Get Faron Pharmaceuticals Oy's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Faron Pharmaceuticals Oy in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access